ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

0ABW Egetis Therapeutics Ab (publ)

0,00
0,00 (0,00%)
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)SEK (SEK)
Revenu total 971k13,59M28,21M82,56M40,66M38,5M22,6M57,6M
Revenu d'exploitation -38,06M-87,13M-87M-66,61M-178,15M-105,6M-197M-324,8M
Revenu avant impôt -38,22M-87,94M-85M-61,42M-179,12M-104,5M-193,8M-326,8M
Revenu net -38,22M-87,94M-85M-61,42M-179,12M-104,5M-193,8M-326,9M
Dividendes privilégiés 00000000
Résultat de base par action -0.785-1.807-1.747-1.147-1.085-0.633-0.903-1.31
EBIT -38,06M-87,13M-87M-66,61M-178,15M-105,6M-197M-324,8M
EBITDA -38,06M-87,13M-87M-66,4M-177,76M-103,2M-194,3M-321,2M